Ayush-82 Anti-Diabetic Drug Goes Commercial 

New Delhi: The National Research Development Corporation (NRDC) of the Department of Scientific & Industrial Research, Ministry of Science & Technology has signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an ayurvedic formulation for prevention and management of  Diabetes.

It has been developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an apex organization for research in Ayurveda under the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy).

Dr. H. Purushotham, Chairman & Managing Director NRDC, Prof. Vd. K.S. Dhiman, Director General of CCRAS and Senior Executives/Scientists of NRDC and CCRAS were present during the event.

Prof. Dhiman elaborated on the formulation and its benefits, while Dr. H. Purushotham said that patients prefer Ayurvedic drugs and in the recent past NRDC had licensed 12 Ayurvedic drugs developed by CCRAS to 32 companies in India.

Kudos Laboratories India will now be able to commercialize this product under their trade name with due acknowledgement to CCRAS, Ministry of AYUSH, Government of India.